Compound Detail
CHEMBL3318007
PIMODIVIR 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
O=C(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F
Basic Information
| ChEMBL ID | CHEMBL3318007 |
| Name | PIMODIVIR |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | JGPXDNKSIXAZEQ-SBBZOCNPSA-N |
6
Targets
21
Activities
4
Assay Types
18
PK Parameters
20
Publications
10
Known Names
3
Indications
1
Mechanisms
Molecular Properties
399.4
MW (Da)
3.60
ALogP
5
HBA
3
HBD
103.8
PSA (Ų)
0.62
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Polymerase basic protein 2 inhibitor | INHIBITOR | Polymerase basic protein 2 | ✓ | ✓ |
Indications
Influenza, Human Kidney Failure, Chronic Liver Diseases
Activity Summary
EC50 14 meas. best 10.0
Kd 3 meas. best 7.3
IC50 2 meas. best 8.7
Ki 2 meas. best 5.8
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Influenza A virus CHEMBL613740 | EC50 | 10.0 | 9.235 | 0.1 | 6 |
| NON-PROTEIN TARGET CHEMBL3879801 | EC50 | 9.23 | 8.736 | 0.6 | 5 |
| Polymerase basic protein 2 CHEMBL3317339 | EC50 | 9.22 | 9.22 | 0.6 | 1 |
| Influenza A virus CHEMBL613740 | IC50 | 8.7 | 8.7 | 2.0 | 1 |
| Polymerase basic protein 2 CHEMBL3317339 | IC50 | 8.4 | 8.4 | 4.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 8.4 | 7.07 | 4.0 | 2 |
| Unchecked CHEMBL612545 | Kd | 7.3 | 7.23 | 50.0 | 2 |
| Polymerase basic protein 2 CHEMBL3317339 | Kd | 7.27 | 7.27 | 54.0 | 1 |
| Glycogen synthase kinase-3 CHEMBL2095188 | Ki | 5.8 | 5.8 | 1600.0 | 1 |
| Glycogen synthase kinase-3 beta CHEMBL262 | Ki | 5.8 | 5.8 | 1600.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 500.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 22000.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 541.99 | ng.hr.mL-1 | Mus musculus |
| AUC | 5343.97 | ng.hr.mL-1 | Mus musculus |
| CL | 26.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 30.9 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 200.3 | nM | Rattus norvegicus |
| Cmax | 45067.6 | nM | Mus musculus |
| Cmax | 2053.0 | nM | Mus musculus |
| F | 26.0 | % | Rattus norvegicus |
| F | 100.0 | % | Mus musculus |
| T1/2 | 3.5 | hr | Rattus norvegicus |
| T1/2 | 2.417 | hr | Homo sapiens |
| T1/2 | 2.417 | hr | Rattus norvegicus |
| T1/2 | 2.417 | hr | Mus musculus |
| T1/2 | 1.9 | hr | Mus musculus |
| Tmax | 2.5 | hr | Mus musculus |
| Vd | 7.1 | L.kg-1 | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine